No Prescription |
 |
 | ||
|
ISMO Imdur |
|
| ||
No Prescription » Prescription Drugs 9 » ISMO Imdur Isosorbide is used to prevent or treat chest pain (angina). It works by relaxing the blood vessels to the heart so the blood and oxygen supply to the heart is increased.Isosorbide comes as a regular sublingual chewable and extended-release (long-acting) tablet and extended-release (long-acting) capsule to be taken by mouth. The tablet usually is taken every 6 hours. The extended-release tablet usually is taken one or two times a day. The extended-release capsule usually is taken every 8-12 hours. Do not crush chew or divide the extended-release tablets or capsules. The sublingual or chewable tablet is used as needed to relieve chest pain that has already started or to prevent pain before activities known to provoke attacks (e.g. climbing stairs sexual activity heavy exercise or being outside in cold weather). The chewable tablet also may be used every 2-3 hours to prevent chest pain. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take isosorbide exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Isosorbide controls chest pain but does not cure it. Continue to take isosorbide even if you feel well. Do not stop taking isosorbide without talking to your doctor. Stopping the drug abruptly may cause chest pain.Isosorbide can lose its effectiveness when used for a long time. This effect is called tolerance. If your angina attacks happen more often last longer or are more severe call your doctor.If you are using isosorbide sublingual or chewable tablets for acute chest pain you should carry the tablets with you at all times. If you are taking isosorbide and your chest pain is not relieved within 5-10 minutes take another dose. Call for emergency assistance or go to a hospital emergency department if pain persists after you have taken three tablets (at 5-10-minute intervals) and 15-30 minutes have passed.When an attack occurs sit down. If you use chewable tablets chew a tablet thoroughly and swallow it. To use the sublingual tablets place a tablet under your tongue or between your cheek and gum and allow it to dissolve. Do not swallow the tablet. Try not to swallow saliva too often until the tablet dissolves.Other uses for this medicine Isosorbide tablets are also used with other drugs to treat congestive heart failure. Buy ISMO Imdur and other Prescription Drugs 9 products online at Medstore. Buy Online at Medstore - Click Here!
About ISMO Imdur: Product Type: Prescription Drugs 9 ISMO ( Imdur Monoket Generic Isosorbide Mononitrate ) ISMO (Imdur Monoket Generic Isosorbide Mononitrate) Imdur Monoket Generic Isosorbide Mononitrate 10mg Tabs 20mg Tabs 40mg Tabs 100 (10 x 10) 98 (14 x 7) Imdur Monoket Generic Isosorbide Mononitrate ISMO
View more Prescription Drugs 9 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
